Periodontal regeneration: the limitations of passive scaffolds facing the challenge of restitution ad integrum
Periodontitis, a chronic inflammatory disease, leads to irreversible destruction of the attachment complex, including the periodontal ligament, cementum and alveolar bone. While conventional non-surgical therapies and open flap debridement control the bacterial load, they generally result in simple scar repair rather than true tissue regeneration.
The emergence of structural biomaterials (scaffolds) over the past decade has opened up new perspectives by mimicking the extracellular matrix. These devices aim to provide a three-dimensional (3D) architecture favourable to cell adhesion, migration and differentiation.
However, the current analysis highlights a critical limitation: used alone, these scaffolds act as passive structural matrices. Their clinical success inherently depends on the host biological environment, local vascularisation and the immune response, thus limiting their predictable regenerative potential.
Study methodology
This literature review analyses the performance of the different types of scaffolds used in periodontal regeneration:
- Natural polymers: notably collagen and chitosan.
- Synthetic polymers: such as PLA (polylactic acid) and PGA (polyglycolic acid).
- Composite structures: combining multiple materials to optimise mechanical stability and biocompatibility.
Limitations of passive structural matrices
The study demonstrates that scaffolds, whilst essential for providing a supportive framework, possess limited regenerative capacity when not bio-activated. Their role remains primarily passive, serving as a physical guide rather than a biological driver. Successful integration depends more on the quality of the recipient site than on the intrinsic properties of the material alone.
The challenge of coordinated regeneration
True periodontal regeneration requires the coordinated and simultaneous formation of three distinct tissues: bone, cementum and the periodontal ligament. Data indicate that conventional treatment modalities and first-generation scaffolds struggle to orchestrate this complex biological response, often being limited to mechanical stability without specific tissue induction.
In practical terms, for the practitioner:
- Mechanical stability: Favour scaffolds (natural or synthetic) for their role in space maintenance and 3D support, while remaining aware of their initial biological passivity.
- Environnement biologique : Évaluez systématiquement la vascularisation et l'état inflammatoire du site hôte, car ces facteurs conditionnent la performance finale de la matrice implantée.
- Objectif clinique : Ne confondez pas réparation (cicatrisation par long épithélium de jonction) et régénération (nouveau cément, os et ligament), cette dernière restant difficile à obtenir avec des matériaux seuls.
Lexique technique de l'étude
Scaffold : Structure tridimensionnelle poreuse servant de matrice temporaire pour guider la croissance et la régénération tissulaire.
Ligament parodontal : Tissu conjonctif fibreux reliant la racine de la dent à l'os alvéolaire, essentiel à la fonction de soutien et de proprioception.
Cément : Couche de tissu minéralisé recouvrant la racine dentaire, permettant l'ancrage des fibres du ligament parodontal.
Polymères synthétiques (PLA/PGA) : Matériaux résorbables produits chimiquement, utilisés pour leur biodégradabilité contrôlée et leur stabilité mécanique.
Régénération vs Réparation : La régénération est la restitution architecturale et fonctionnelle complète du tissu perdu, tandis que la réparation est une guérison qui ne restaure pas l'anatomie originale.
Source
- Titre original : Role of Adjunctive Biologic Agents in Scaffold-based Periodontal Regeneration: A Systematic Review
- Auteurs : Varun Batra, Jaiganesh Ramamurthy
- Publication : 2026-05-21
- DOI : https://doi.org/10.5005/jp-journals-10015-2794
Information destinée aux professionnels de santé. Ce contenu peut comporter des erreurs ou des résumés tronqués. Nous recommandons de toujours vérifier avec l'article source original. Delynov se décharge de toute responsabilité quant à l'utilisation de ces informations. Ce document n'est pas destiné aux patients ni au grand public.